Teva Pharmaceutical Industries Ltd., the world's biggest maker of generic drugs, and Kowa Co. have agreed to form a joint venture to gain a share of the growing market for cheaper medicines in Japan.
They expect the business, Teva-Kowa Pharma Co., to generate sales of $1 billion in 2015, Teva, based in Petah Tikva, Israel, said Wednesday. Each company will have a 50 percent stake in the venture, which will be operational in 2009.
Teva seeks to break into the $65 billion a year Japanese drug market as the country tries to reduce health care costs by developing more incentives for pharmacists to dispense generics.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.